|
1. Anti-dsDNA
Anti-dsDNA
is intended for the in-vitro measurement of specific IgG autoantibodies
against double stranded deoxyribonucleic acid (dsDNA) present in
human serum, as an aid in the diagnosis of systemic lupus erythematosus
(SLE), in conjuction with other clinical findings.
Autoantibodies
to DNA recognise either single stranded (ss) or double stranded
(ds)forms of DNA. Anti-ssDNA autoantibodies are not disease specific,
being associated with a range of autoimmune conditions including;
drug induced systemic lupus erythematosus, mixed connective tissue
disease, rheumatoid arthritis, scleroderma and Sjogren's syndrome.
In
contrast, anti-dsDNA autoantibodies are associated more specifically
with SLE, where immune complex formation is thought to play a major
role in the pathogenesis of the disease. The deposition of immune
complexes leads to inflamation and the renal and vascular characteristics
of the disease.
Sudden
increases in SLE disease activity are generally preceded by a rise
in anti-dsDNA levels, followed by a steep drop at the height of
the disease. This observation confirms the necessity of monitoring
the level of anti-dsDNA autoantibodies in SLE patients on a regular
basis.
Laboratory
Testing
| Method |
ELISA |
| Specimen
Requirement |
5ml
plain blood |
| Laboratory
Interpretation |
Negative
(<30 IU/ml) |
| Borderline
(30-75 IU/ml) |
| Positive
(>75 IU/ml) |
| Turnaround
Time |
1
week |
Please
contact our lab for further information
2.
Anti-Cardiolipin Antibody
Antiphospholipid
antibodies, including anti-cardiolipin antibodies, are frequently
detected in sera from patients with systematic lupus erythematosus.
Numerous reports have associated these autoantibodies with various
venous and arterial thrombotic disorders, including cerebral infarction,
deep venous thrombosis, thrombocytopenia, plumonary embolism and
recurrent fetal loss with placental infarction.
In SLE and SLE-like
conditions, antiphospholipids are thought to occur in between 18-61%
of the patients. In the general population, the prevalence is 0-14%.
So, the presence of antiphospolipids would give weight to an existing
diagnosis, or certainly point toward SLE as a consideration.
Laboratory
Testing
| Method |
:
ELISA |
| Specimen |
:
5ml plain blood |
| Turnaround
Time |
:
1 week |
| Laboratory
Interpretation |
:
Positive (Absorbance >= cut off value) |
|
Negative (Absorbance < cut off value) |
Please
contact our lab for further information
Back
to Brochures Index
|